All You Need to Know About Rapid Covid Test Kits
(Bloomberg) -- The emergence of the omicron variant is spurring a scramble for Covid-19 lateral flow tests, to try and ensure safe holiday parties and family gatherings. The U.K. is dealing with a supply crunch for these cheaper, quicker tests -- known as rapid tests in the U.S. -- after health officials said last week they are as effective at picking up omicron as delta, the previous most infectious strain.
In the U.S., President Joe Biden said he will deliver 500 million free Covid-19 tests to people's homes starting next month and dispatch the military to shore up overwhelmed hospitals as the U.S. confronts a resurgent pandemic. New York is already handing out rapid test kits, while Vermont issued a mandate that helps people cover testing costs through their insurers in a move that could soon become a federal requirement.
When should you get tested after potential exposure to Covid-19?
The best time to test is two or three days after exposure to someone who has the virus, according to Irene Petersen, a professor of epidemiology at University College London. That's because it varies when people start to become infectious. If you sat next to someone who had the virus on Friday, then you should get a test on Monday.
I'm going to a Christmas party. When should I get tested?
Right before you leave your house, Petersen said. Don't trust a two-day old negative test, “you might have become infectious in between.”
Can I trust a negative lateral flow result?
Don't rely on one test taken a few days after exposure, Petersen said. You should continue to get tested up to about a week after exposure to the virus.
So you tested positive. Now what?
It is best to trust the rapid test first of all.
“It's very likely you have Covid if you get a positive lateral flow test,” Petersen said. There are reportedly fewer than one false positive in every 1,000 lateral flow tests carried out.
The official line in the U.K. is after a positive rapid test you should do a PCR test and self-isolate until you get your result confirmed. If a PCR within two days of a rapid test is positive, then you should start isolating for 10 days. If you take a PCR later than that, no matter the result you'll still have to isolate for the full 10 days.
Petersen advises people to stay at home straight away after a positive rapid test, especially if they start having symptoms. “If you have a fever or a runny nose, and a positive lateral flow test, it is infectious,” she said.
What's the difference between rapid tests and PCRs?
A lateral flow test investigates whether you have proteins from the virus in your body. You're most likely to have a high level of these proteins when you're most infectious -- so it may be less accurate just after infection or toward the end of your illness. It's also known as a rapid test because it can be taken at home and gives you the results in as little as 15 minutes.
A PCR test, which identifies the genetic material from the virus, has to be checked and interpreted by a laboratory. It can take up to two days to get your results, and they're also more expensive than lateral flows. PCRs are more sensitive at picking up the virus, because the genetic material you might have in your samples is amplified in the lab. That means it can pick up the illness earlier than the rapid test. A PCR can detect the virus as early as day two and up to 16 days after infection, according to the Robert Koch Institute.
With a PCR you may test positive even if you're not infectious anymore, as you could still have some genetic material from the virus, Petersen said.
How do you get your hands on a lateral flow test?
In England, you can pick-up rapid tests from a pharmacy, order a kit from the list of providers found on the government website or you can go to a test site. Schools, colleges and nurseries and some employers and universities also provide rapid tests free of charge.
©2021 Bloomberg L.P.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.